Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Sarcoma 1Primary Myelofibrosis 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1Breast Neoplasms 1

Interventions

Specimen Handling 2Biopsy 2Azacitidine 2venetoclax 1veliparib 1pevonedistat 1peginterferon alfa-2b 1fludarabine phosphate 1axatilimab 1Whole-Body Irradiation 1Topotecan 1Tacrolimus 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Hyperbaric Oxygenation 1Etoposide 1Cyclosporine 1Cyclophosphamide 1Carboplatin 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative × Hyperbaric Oxygenation × 90 days × Clear all
NCT03964506 2026-06-03

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

University of Rochester

Phase EARLY_PHASE1 Recruiting
24 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡